Hi-Tech Pharmacal Co. (NASDAQ:HITK) continues to trade at great valuations and have plenty of earnings momentum. Company Description Hi-Tech Pharmacal makes generic and branded pharmaceuticals, both over-the-counter and prescription. The company focuses on liquid and semi-solid forms for ophthalmic, otic, and inhalable products. Another Surprise Hi-Tech Pharmacal reported quarterly results on Mar 11 that yielded EPS of 67 cents, ...